Crispr Therapeutics AG (CRSPN) Q4 2024 Earnings Report
MX:CRSPN Q4 2024 EPS Results
- Actual EPS
- -MXN 8.27
- Consensus EPS
- -MXN 22.57
- Beat/Miss
- Beat by +MXN 14.30
- One Year Ago EPS
- MXN 20.67
MX:CRSPN Q4 2024 Revenue Results
- Actual Revenue
- MXN 670.71M
- Expected Revenue
- MXN 151.37M
- Beat/Miss
- Beat by +MXN 519.34M
- YoY Revenue Growth
- -82.26%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/11/2025
- Time
- After Close
- Conference Call
- Tuesday, February 11, 2025
MX:CRSPN Upcoming Earnings
Crispr Therapeutics AG's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:CRSPN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | -19.49-21.61 | -21.99 | 1.71% (+0.38) | ― |
| Aug 03, 2026 | 2026 (Q2) | -22.46-17.66 | -45.1 | 60.83% (+27.44) | |
| May 04, 2026 | 2026 (Q1) | -22.89-24.05 | -29.69 | 18.99% (+5.64) | |
| Feb 12, 2026 | 2025 (Q4) | -21.86-25.75 | -8.27 | -211.36% (-17.48) | |
| Nov 10, 2025 | 2025 (Q3) | -23.77-21.99 | -18.98 | -15.84% (-3.01) | |
| Aug 04, 2025 | 2025 (Q2) | -26.35-45.10 | -28 | -61.07% (-17.10) | |
| May 06, 2025 | 2025 (Q1) | -23.38-29.69 | -26.87 | -10.49% (-2.82) | |
| Feb 11, 2025 | 2024 (Q4) | -22.57-8.27 | 20.67 | -140.00% (-28.94) | |
| Nov 05, 2024 | 2024 (Q3) | -26.46-18.98 | -26.5 | 28.37% (+7.52) | |
| Aug 05, 2024 | 2024 (Q2) | -26.82-28.00 | -18.42 | -52.04% (-9.58) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
